India got a new weapon to fight against Corona, approved the third vaccine developed in the country

New Delhi | fight against COVID-19India has got another weapon in the war with Corona. The Health Ministry has approved two more vaccines for emergency use. The names of these two vaccines are CORBEVAX and COVOVAX. Apart from this, an anti-viral drug Molnupiravir has also been approved.

To be used in the treatment of adult patients

Molnupiravir is an anti-viral drug, which will now be manufactured by 13 companies in the country. It will be used in the treatment of adult Kovid patients in case of emergency. Health Minister Mansukh Mandaviya has given this information.

Also read:- Mastermind of Ludhiana bomb blast arrested, many sensational revelations happening in interrogation

Third vaccine developed in India
fight against COVID-19Giving information, the Health Minister said that CORBEVAX vaccine is India’s first indigenously developed RBD protein sub-unit vaccine. It has been made by Hyderabad based firm Biologicals-E. This is the third vaccine developed in India. The health minister said the nanoparticle vaccine, Kovovax, will be manufactured by the Pune-based firm Serum Institute of India.

Also read:- BCCI President and former Indian captain Sourav Ganguly found corona positive, treatment going on in hospital

Congratulations India

Further strengthening the fight against COVID-19, CDSCO, @MoHFW_INDIA has given 3 approvals in a single day for:

– CORBEVAX vaccine
– COVOVAX vaccine
– Anti-viral drug Molnupiravir

For restricted use in emergency situation. (1/5)

— Dr. Mansukh Mandaviya (@mansukhmandviya) December 28, 2021

Permission was sought for approval in emergency
Let us tell you that Serum Institute of India had applied for permission to DCGI in October to approve Kovovax for limited use in emergency.

Also read:- PM Narendra Modi got India’s most expensive Mercedes-Maybach worth Rs 12 crore, this is a special feature along with facing the blasts